Consolidatory ablative stereotactic body radiation therapy after induction chemotherapy for unresectable pancreatic cancer: A single center experience.

Front Oncol · 2022 · PMC9733675 · PMID 36505838

Europe PMC DOI

hedged sentence

0.0840

closest p · 1.7× alpha

0.0840

boldest claim

The sentences

showed a trendp=0.084so close (0.05 < p ≤ 0.1)

Patients treated with MR-guided adaptive SBRT showed a trend toward lower rates of late adverse events compared with those treated with non-adaptive SBRT (grade 2: 19.2% vs. 33.3%; grade 3: 0% vs. 8.3%; p=0.084).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.